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Background and aims: Although there are many works 
devoted to this problem, particularities of cerebral 
hemodynamic in patients with arteriovenous malformations 
(AVM) are poorly described.
Aims: Research the influence of arteriovenous shunting at 
the reorganization of cerebral hemodynamics in patients 
with AVM.
Methods: Between 2005 and 2016 years 357 consecutive 
patients with brain AVM were treated in Dnepropetrovsk 
regional hospital. We conducted a comprehensive clinical, 
neuropsychological and neuroimaging examination of this 
subjects. 
Results: The relative increase of the linear velocity of blood 
flow (LBV) in the arteries feeding AVM was 143% 
(145.56±15.57 cm/s). Increasing of blood volume flowing 
through the AVM lead to significant increasing of total 
cerebral blood flow till 1679.05±448.03 ml\min (exceede 
normal range in 2 times). Lesion of autoregulation was 
found in 75% of patients with AVM during conducting of 
functional tests. During hyperventilation LBV decreased in 
average on 25±7.4% (significant lower (р 0.01) than 
normal). Response to hypercapnia was absent in 37.5%. 
Overshoot ratio in averaged 1.06±0.07. On computed 
tomography perfusion the cerebral blood flow (CBF) and 
cerebral blood volume (CBV) were markedly elevated 
within the AVM nidus. However, the perinidal areas 
demonstrated low CBF and CBV, suggestive of perinidal 
ischemia in follow areas: surrounding AVM-in 91.5%, 
remoted  from AVM in the ipsilateral hemisphere-in 61% of 
cases;  in the contralateral hemisphere - in 34.4%.
Conclusion: We have shown that features of cerebral 
gemodynamics depends on the structural and functional 
characteristics of AVM.
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Background and aims: Low-dose rtPA is currently used in 
Japanese subjects (Yamaguchi, Stroke 2006) with acute 
ischemic stroke, while it was not shown to be non-inferior 
to standard dose in a recent trial involving predominantly 
Asian subjects (Anderson, NEJM 2016). We aimed to 
evaluate safety and efficacy of low-dose rtPA in a Caucasian 
cohort of acute stroke patients.
Methods: From our database, among 389 rtPA-treated 
patients we consecutively selected 19 subjects treated with 
low-dose rtPA (≤0.75 mg/kg), matched by NIHSS score, 
age and onset-to-treatment time to 38 subjects treated with 
standard-dose rtPA (0.9 mg/kg). Primary efficacy outcome 
was defined by favourable 90-days functional outcome 
(mRS score≤2). Secondary efficacy outcomes were NIHSS 
score and mRS at discharge. Safety outcome was the 
proportion of symptomatic ICH (according to SITS-MOST 
criteria) and death.
Results: Baseline clinical and demographic features were 
similar between groups. At discharge, low-dose rtPA 
patients had NIHSS and mRS scores comparable to control 
group (p=0.659; p=0.520). Good functional outcome 
occurred in 47.4% low-dose subjects vs. 52.6% in standard-
dose group (p=0.925). In addition, the distribution of mRS 
scores at 90 days was not significantly different between the 
two treatment groups (p=0.987). The proportion of sICH 
and death similar as well (p=1.000).
Table 1. Baseline clinical and demographic characteristics.
